Home / Pharmaceutical company intelligence
Helix Pharma (Pvt)., Ltd. logo
Pharmaceutical company intelligence

Helix Pharma products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Karachi · Pakistan

Karachi pharmaceutical manufacturer with a history dating to 1960 and a broad prescription and consumer-health portfolio.

Helix Pharma products in Pakistan

Helix Pharma (Pvt)., Ltd has 113 medicine presentations registered in Pakistan under 49 brands, covering 45 generic medicines. Most of its products are in Anti-infectives, Oncology & immunology and CNS & mental health. Its brands with the most registered strengths and packs are Relidomide (Lenalidomide), Eplipsa (Levetiracetam), Hilixophin (Ceftriaxone) and Recept (Risperidone). 113 products have an official DRAP price on MedInfoBase. See all 49 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation11 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date27 Jul 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Helix Pharma (Pvt.) Limited
Company type
Private pharmaceutical manufacturer
Address
A-56 Manghopir Road, Metroville, S.I.T.E., Karachi, Pakistan
Phone
+92 21 111 475 475
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000030 Helix Pharma (Pvt) Ltd. · Sindh
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000030 113 linked products · source seen 11 Nov 2026 View source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx125public portfolio records represented
REG107unique registrations represented
IDX113indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+12registry-only registrations
VER66registry-verified exact registrations
PKR113current validated price records
G45generic molecules in indexed catalogue
DF8dosage-form groups
TA9therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage90%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage93%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixHelix Pharma (Pvt)., Ltd.Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/helix-pharma-pvt-ltdGenerated 11 Nov 2026Anti-infectives51 · 45%Oncology & immunology27 · 24%CNS & mental health13 · 12%Hematology & thrombosis6 · 5%Vitamins, minerals & nutrition6 · 5%Respiratory & allergy4 · 4%Reproductive & genitourinary3 · 3%Other therapeutic areas3 · 3%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioHelix Pharma (Pvt)., Ltd.Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/helix-pharma-pvt-ltdGenerated 11 Nov 2026113presentationsTablet44 · 39%Injection36 · 32%Capsule13 · 12%Suspension11 · 10%Solution3 · 3%Drops2 · 2%Other forms4 · 4%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionHelix Pharma (Pvt)., Ltd.Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/helix-pharma-pvt-ltdGenerated 11 Nov 2026105comparable productsBelow peer median32 · 30%Near peer median42 · 40%Above peer median31 · 30%Company median price position+0.0%Lowest-price equivalents11Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsHelix Pharma (Pvt)., Ltd.Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/helix-pharma-pvt-ltdGenerated 11 Nov 2026Pharmasol (Pvt) Ltd.30 shared67% overlapMacter International Limited27 shared60% overlapM/s. Genix Pharma (Pvt) Ltd.26 shared58% overlapCCL Pharmaceuticals (Pvt.) Limited26 shared58% overlapMartin Dow Limited26 shared58% overlapNabiqasim Industries (Pvt) Ltd.,25 shared56% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Formulation footprint

Dosage forms

Tablet44 products
Injection36 products
Capsule13 products
Suspension11 products
Solution3 products
Drops2 products
Infusion2 products
Syrup2 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Helix Pharma (Pvt)., Ltd. is priced against the market

105 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers95Distinct registrations among indexed, published, presentation-validated products only
Verified price observations114
Products with a verified price113
Products with multiple price observations1
Source records with multiple versions113
Latest portfolio source check22 Sep 2026
Latest effective price date27 Jul 2026
Latest source observation11 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

107 unique registration(s) · 113 indexed presentation(s) · 12 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Artepip 40/320 Dihydroartemisinin + Piperaquine 40 mg + 320 mg Capsule 8's 061029 PKR 621.28 PKR 77.66/capsule 🔒 Pharma Pro
Aslow - 81 EachEnteric Coated Acetylsalicylic acid (Aspirin) 81 mg Tablet 3x10's 076199 PKR 32.54 PKR 1.08/tablet 🔒 Pharma Pro
Ayzed Azithromycin 200 mg/5 mL Suspension 30ml 028092 PKR 452.87 PKR 15.10/mL 🔒 Pharma Pro
Ayzed Azithromycin 200 mg/5 mL Suspension 15ml 028092 PKR 320.35 PKR 21.36/mL 🔒 Pharma Pro
Ayzed Azithromycin 500 mg Tablet 1 x 6's 067044 PKR 533.91 PKR 88.99/tablet 🔒 Pharma Pro
Bicluta Bicalutamide 50 mg Tablet 28's 116038 PKR 6,390.05 PKR 228.22/tablet 🔒 Pharma Pro
Carbol Carboplatin 150 mg/15 mL Injection 1's 072505 PKR 4,108.65 PKR 4,108.65/vial/unit 🔒 Pharma Pro
Carbol Carboplatin 450 mg/45 mL (10 mg/mL) Injection 1's 072506 PKR 8,217.31 PKR 8,217.31/vial/unit 🔒 Pharma Pro
Citabol Gemcitabine 200 mg Lyophilized powder for injection 1's 106858 PKR 3,537.85 PKR 3,537.85/vial/unit 🔒 Pharma Pro
Citabol Gemcitabine 1000 mg Injection 1's 106859 PKR 12,284.11 PKR 12,284.11/vial/unit 🔒 Pharma Pro
Clotamax Tranexamic acid 500 mg/5 mL Injection 10x5ml 035439 PKR 646.30 PKR 12.93/mL 🔒 Pharma Pro
Clotamax Tranexamic acid 250 mg/5 mL Injection 10x5ml 037334 PKR 276.99 PKR 5.54/mL 🔒 Pharma Pro
Cocard Clopidogrel 75 mg Tablet 1x10’s 033810 PKR 271.81 PKR 27.18/tablet 🔒 Pharma Pro
Cocard Plus 75/75 Clopidogrel + Aspirin 75 mg + 75 mg Tablet 1 x 10's 080662 PKR 281.52 PKR 28.15/tablet 🔒 Pharma Pro
CS-SUM Injection 1gmRegistry verified Cefoperazone as sodium, Sulbactum as sodium — — — 107481Official source ↗ No indexed price — —
CS-SUM Injection 2gmRegistry verified Cefoperazone as sodium, Sulbactum as sodium — — — 107482Official source ↗ No indexed price — —
CS-SUM Injection 500mgRegistry verified Cefoperazone as Sodium, Sulbactum as sodium — — — 118263Official source ↗ No indexed price — —
Cytomib Bortezomib 3.5 mg Lyophilized powder for injection 1's 106860 PKR 48,623.87 PKR 48,623.87/vial/unit 🔒 Pharma Pro
Declar Daclatasvir 30 mg Tablet 28's 086672 PKR 5,137.20 PKR 183.47/tablet 🔒 Pharma Pro
Declar Daclatasvir 60 mg Tablet 28's 086673 PKR 8,405.66 PKR 300.20/tablet 🔒 Pharma Pro
Diaxin Clarithromycin 125 mg/5 mL Oral suspension 60 ml 030596 PKR 378.58 PKR 6.31/mL 🔒 Pharma Pro
Diaxin Clarithromycin 250 mg Tablet 1x10's 034109 PKR 443.18 PKR 44.32/tablet 🔒 Pharma Pro
Diaxin Clarithromycin 500 mg Tablet 1x10's 034110 PKR 821.73 PKR 82.17/tablet 🔒 Pharma Pro
Doris Cholecalciferol 5 mg/mL (200,000 IU/mL) Oral/IM ampoule 1 x 5's 076441 PKR 906.68 PKR 181.34/ampoule No comparator
Doris Cholecalciferol 5 mg/mL (200,000 IU/mL) Oral/IM ampoule 1 x 1's 076441 PKR 213.57 PKR 213.57/ampoule No comparator
EM-Fera Empagliflozin 10 mg Tablet 14's 115871 PKR 1,261.97 PKR 90.14/tablet 🔒 Pharma Pro
EM-Fera Empagliflozin 25 mg Tablet 14's 115872 PKR 1,510.49 PKR 107.89/tablet 🔒 Pharma Pro
Eplipsa Levetiracetam 250 mg Tablet 3 x 10's 075916 PKR 1,779.02 PKR 59.30/tablet 🔒 Pharma Pro
Eplipsa Levetiracetam 500 mg Tablet 10's 075917 PKR 983.32 PKR 98.33/tablet 🔒 Pharma Pro
Eplipsa Levetiracetam 500 mg/5 mL Injection 1'sx5ml 075918 PKR 639.72 PKR 127.94/mL 🔒 Pharma Pro
Eplipsa Levetiracetam 500 mg/5 mL Injection 10'sx5ml 075918 PKR 6,390.45 PKR 127.81/mL 🔒 Pharma Pro
Eplipsa Levetiracetam 100 mg/mL Oral solution 120ml 082200 PKR 1,627.57 PKR 13.56/mL 🔒 Pharma Pro
Eplipsa Levetiracetam 100 mg/mL Oral solution 30ml 082200 PKR 429.50 PKR 14.32/mL 🔒 Pharma Pro
Eplipsa Levetiracetam 100 mg/mL Oral solution 60ml 082200 PKR 813.78 PKR 13.56/mL 🔒 Pharma Pro
Eplipsa XR Levetiracetam 500 mg Tablet 1x10's 091237 PKR 1,006.64 PKR 100.66/tablet 🔒 Pharma Pro
Erlotirel Erlotinib 100 mg Tablet 30's 110564 PKR 32,985.27 PKR 1,099.51/tablet 🔒 Pharma Pro
Erlotirel Erlotinib 150 mg Tablet 30's 110565 PKR 41,272.20 PKR 1,375.74/tablet 🔒 Pharma Pro
Fotiflox Moxifloxacin 400 mg Tablet 1x5’s 035337 PKR 922.21 PKR 184.44/tablet 🔒 Pharma Pro
Fugix Fluconazole 50 mg Capsule 1x7’s 032929 PKR 780.48 PKR 111.50/capsule 🔒 Pharma Pro
Fugix Fluconazole 150 mg Capsule 1’s 032930 PKR 340.92 PKR 340.92/capsule 🔒 Pharma Pro
Fugix Fluconazole 50 mg/5 mL Suspension 35ml 032931 PKR 407.72 PKR 11.65/mL 🔒 Pharma Pro
Hi-Sunate Artesunate 30 mg Injection 1's 086060 PKR 142.71 PKR 142.71/vial/unit 🔒 Pharma Pro
Hi-Sunate Artesunate 60 mg IV/IM injection 1's 086061 PKR 232.98 PKR 232.98/vial/unit No comparator
Hi-Sunate Artesunate 120 mg Injection 1's 086062 PKR 396.42 PKR 396.42/vial/unit 🔒 Pharma Pro
Hilixophin Ceftriaxone 250 mg Injection 1's 105496 PKR 210.99 PKR 210.99/vial/unit 🔒 Pharma Pro
Hilixophin Ceftriaxone 1 g Injection 1's 105497 PKR 670.58 PKR 670.58/vial/unit 🔒 Pharma Pro
Hilixophin Ceftriaxone 500 mg Injection 1's 105498 PKR 355.13 PKR 355.13/vial/unit 🔒 Pharma Pro
Hilixophin Ceftriaxone 250 mg Injection 1's 107483 PKR 210.99 PKR 210.99/vial/unit 🔒 Pharma Pro
Hilixophin Ceftriaxone 500 mg Injection 1's 107484 PKR 355.13 PKR 355.13/vial/unit 🔒 Pharma Pro
Hilixophin Ceftriaxone 1 g Injection 1's 107485 PKR 670.58 PKR 670.58/vial/unit 🔒 Pharma Pro
A to Z

All 49 Helix Pharma brands in Pakistan

  • Artepip 40/320 Dihydroartemisinin + Piperaquine · 40 mg + 320 mg capsule
  • Aslow - 81 EachEnteric Coated Acetylsalicylic acid (Aspirin) · 81 mg tablet
  • Ayzed Azithromycin · 200 mg/5 mL suspension, 500 mg tablet
  • Bicluta Bicalutamide · 50 mg tablet
  • Carbol Carboplatin · 150 mg/15 mL injection, 450 mg/45 mL (10 mg/mL) injection
  • Citabol Gemcitabine · 1000 mg injection, 200 mg injection
  • Clotamax Tranexamic acid · 250 mg/5 mL injection, 500 mg/5 mL injection
  • Cocard Clopidogrel · 75 mg tablet
  • Cocard Plus 75/75 Clopidogrel + Aspirin · 75 mg + 75 mg tablet
  • Cytomib Bortezomib · 3.5 mg injection
  • Declar Daclatasvir · 30 mg tablet, 60 mg tablet
  • Diaxin Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
  • Doris Cholecalciferol · 5 mg/mL (200,000 IU/mL) injection
  • EM-Fera Empagliflozin · 10 mg tablet, 25 mg tablet
  • Eplipsa Levetiracetam · 100 mg/mL solution, 250 mg tablet, 500 mg tablet
  • Eplipsa XR Levetiracetam · 500 mg tablet
  • Erlotirel Erlotinib · 100 mg tablet, 150 mg tablet
  • Fotiflox Moxifloxacin · 400 mg tablet
  • Fugix Fluconazole · 150 mg capsule, 50 mg capsule, 50 mg/5 mL suspension
  • Hi-Sunate Artesunate · 120 mg injection, 30 mg injection, 60 mg injection
  • Hilixophin Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
  • Hipro Ciprofloxacin · 100 mg tablet, 250 mg tablet, 500 mg tablet
  • Hipro XR Ciprofloxacin · 1000 mg tablet
  • Hitac Ranitidine · 150 mg tablet
  • Hitaxime Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
  • Hitazidime Ceftazidime · 1000 mg injection, 250 mg injection, 500 mg injection
  • Hixopenem Meropenem · 1 g injection, 500 mg injection
  • Ironal Iron polymaltose complex · 100 mg tablet, 50 mg/5 mL syrup
  • Ironal-F Iron polymaltose complex + Folic acid · 100 mg + 0.35 mg tablet
  • Mether Artemether · 40 mg injection
  • Misolix Misoprostol · 100 mcg tablet, 200 mcg tablet
  • Neu peg PF S Pegfilgrastim · 6 mg/0.6 mL injection
  • Oflocin Ear Ofloxacin · 0.3 % drops, 0.6 % drops
  • Oxol Oxaliplatin · 100 mg/50 mL (2 mg/mL) injection, 50 mg/25 mL injection
  • Recept Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
  • Relicitabine Capecitabine · 150 mg tablet, 500 mg tablet
  • Relidomide Lenalidomide · 10 mg capsule, 25 mg capsule, 5 mg capsule
  • Robol Doxorubicin · 10 mg/5 mL injection, 50 mg/25 mL injection
  • Sedol Etoposide · 100 mg/5 mL (20 mg/mL) injection
  • Sofotel Sofosbuvir · 400 mg tablet
  • Tavelor Loratadine · 10 mg tablet, 5 mg/5 mL suspension
  • Trexol Methotrexate · 50 mg/2 mL injection
  • Tycef Cefixime · 400 mg capsule
  • Tycef DS Cefixime · 200 mg/5 mL suspension
  • Tycef Pediatric Cefixime · 100 mg/5 mL suspension
  • Winy Linezolid · 100 mg/5 mL suspension, 400 mg tablet, 600 mg tablet
  • Xeflox Levofloxacin · 250 mg tablet, 500 mg tablet
  • Ximab Rituximab · 100 mg/10 mL (10 mg/mL) infusion, 500 mg infusion
  • Zavir Ribavirin · 400 mg tablet, 600 mg tablet
Questions

Helix Pharma: common questions

How many products does Helix Pharma have in Pakistan?

Helix Pharma (Pvt)., Ltd has 113 registered medicine presentations in Pakistan, sold under 49 brands and covering 45 generic medicines.

What are the main brands of Helix Pharma?

By number of registered strengths and packs, its largest brands are Relidomide (Lenalidomide), Eplipsa (Levetiracetam), Hilixophin (Ceftriaxone), Recept (Risperidone) and Hipro (Ciprofloxacin). This is not a sales ranking.

Which therapy areas does Helix Pharma cover?

The most products are in Anti-infectives (51), Oncology & immunology (27), CNS & mental health (13), Hematology & thrombosis (6) and Vitamins, minerals & nutrition (6).

Where can I see Helix Pharma medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Helix Pharma (Pvt)., Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 11, 2026, from https://medinfobase.com/company/helix-pharma-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9